[HTML][HTML] Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: a network meta-analysis
H Okumura, A Fukushima, V Taieb, S Shoji… - Journal of Infection and …, 2020 - Elsevier
We conducted a systematic review of the literature and network meta-analysis (NMA) to
compare the relative effectiveness of antibiotic treatments for Clostridioides (Clostridium) difficile …
compare the relative effectiveness of antibiotic treatments for Clostridioides (Clostridium) difficile …
Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease
…, H Kaku, H Nakayama, I Miyake, S Shoji… - The Journal of …, 2005 - academic.oup.com
Graves’ disease (GD) is an autoimmune disorder with genetic predisposition. IL-13 is an
important mediator of antiinflammatory immune responses and is expressed in the thyroid and …
important mediator of antiinflammatory immune responses and is expressed in the thyroid and …
Inward rectifier and low-threshold calcium currents contribute to the spontaneous firing mechanism in neurons of the rat suprachiasmatic nucleus
T Akasu, S Shoji, H Hasuo - Pflügers Archiv, 1993 - Springer
Intracellular and voltage-clamp studies were carried out to clarify the mechanism for
spontaneous firing activity in neurons of the suprachiasmatic nucleus (SCN) of rat hypothalamic …
spontaneous firing activity in neurons of the suprachiasmatic nucleus (SCN) of rat hypothalamic …
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 …
A Kashiwagi, S Shoji, Y Kosakai, T Koga… - Journal of Diabetes …, 2023 - Wiley Online Library
Aims/Introduction Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have shown beneficial
effects on cardiometabolic risk factors (hemoglobin A1c, body mass index, systolic blood …
effects on cardiometabolic risk factors (hemoglobin A1c, body mass index, systolic blood …
Chronic cocaine enhances γ-aminobutyric acid and glutamate release by altering presynaptic and not postsynaptic γ-aminobutyric acidB receptors within the rat …
S Shoji, D Simms, WC McDaniel, JP Gallagher - Journal of Pharmacology …, 1997 - ASPET
Cocaine is a popular and sometimes deadly drug of abuse. Its mechanisms of action have
previously not been linked with receptors localized to presynaptic sites for the major central …
previously not been linked with receptors localized to presynaptic sites for the major central …
Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling
I Murata, K Ooi, S Shoji, Y Motohashi… - Journal of Trauma …, 2013 - journals.lww.com
BACKGROUND Crush syndrome (CS) is characterized by ischemia/reperfusion–induced
rhabdomyolysis and the subsequent onset of systemic inflammation. CS is associated with a …
rhabdomyolysis and the subsequent onset of systemic inflammation. CS is associated with a …
Glucose regulation of synaptic transmission in the dorsolateral septal nucleus of the rat
S Shoji - Synapse, 1992 - Wiley Online Library
Intracellular recordings were made from neurons in the dorsolateral septal nucleus (DLSN)
of rat brain slices. Lowering the concentration of extracellular glucose resulted in a …
of rat brain slices. Lowering the concentration of extracellular glucose resulted in a …
Immunohistochemical analysis of bcl-2, Bax and Bak expression in thyroid glands from patients with Graves' disease
…, T Mukai, I Miyake, T Fukutani, M Koga, S Shoji… - Endocrine …, 2004 - jstage.jst.go.jp
In order to clarify the role of apoptosis and the expression of Bcl-2 family proteins in the
pathology of Graves’ disease (GD), we evaluated the apoptosis by in situ end-labeling of …
pathology of Graves’ disease (GD), we evaluated the apoptosis by in situ end-labeling of …
Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl …
A Kashiwagi, S Shoji, S Onozawa… - Journal of Diabetes …, 2022 - Wiley Online Library
Aims/Introduction To evaluate the benefit of sodium–glucose cotransporter 2 inhibitors (SGLT2i)
versus dipeptidyl peptidase‐4 inhibitors (DPP4i) in reducing cardiovascular disease (…
versus dipeptidyl peptidase‐4 inhibitors (DPP4i) in reducing cardiovascular disease (…
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium‐glucose cotransporter 2 inhibitors vs dipeptidyl …
A Kashiwagi, S Shoji, Y Kosakai… - Journal of Diabetes …, 2024 - Wiley Online Library
Aims/Introduction Healthcare resource utilization (HCRU) and healthcare costs are important
factors to consider when selecting appropriate treatment for type 2 diabetes mellitus. We …
factors to consider when selecting appropriate treatment for type 2 diabetes mellitus. We …